Recent News

• 05.28.2025 - Annual Meeting
• 05.28.2025 - Annual Meeting
• 05.12.2025 - Neumora First Quarter 2025 Earnings Conference Call
• 05.12.2025 - Neumora First Quarter 2025 Earnings Conference Call
• 05.12.2025 - Neumora First Quarter 2025 Earnings Conference Call
• 05.12.2025 - Neumora First Quarter 2025 Earnings Conference Call
• 05.12.2025 - Neumora Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
• 05.12.2025 - Neumora Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
• 04.28.2025 - Neumora Therapeutics to Report First Quarter 2025 Financial Results on Monday, May 12, 2025
• 04.28.2025 - Neumora Therapeutics to Report First Quarter 2025 Financial Results on Monday, May 12, 2025

Recent Filings

• 05.12.2025 - 8-K Current report
• 05.12.2025 - EX-99.1 EX-99.1
• 05.12.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.12.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 04.29.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 04.29.2025 - DEF 14A Other definitive proxy statements
• 04.11.2025 - PRE 14A Other preliminary proxy statements
• 04.11.2025 - 8-K/A Current report
• 03.26.2025 - EFFECT Notice of Effectiveness
• 03.12.2025 - 144 Report of proposed sale of securities